Seminars in Oncology Nursing
Volume 25, Issue 1 , Pages 3-14 , February 2009

Review of the Gastrointestinal Tract: From Macro to Micro

References 

  1. Thibodeau GA, Patton KT. Anatomy and physiology. St. Louis, MO: Mosby; 2002;pp. 1354-1372
  2. Huether SE. Structure and function of the digestive system. In:  McCance K,  Huether SE editor. Pathophysiology: The biologic basis for disease in adults and children. St. Louis, MO: Elsevier Mosby; 2006;p. 1353–1383
  3. Johnson LR. In: Gastrointestinal physiology. 7th ed.. Philadelphia, PA: Mosby; 2007;
  4. King D. Study guide: Histology of the gastrointestinal system. 2008. Available at: http://www.siumed.edu/∼dking2/erg/giguide.htm (accessed March 25, 2008).
  5. Sherwood L. The digestive system. Fundamentals of physiology: A human perspective. 3rd ed.. Pacific Grove, CA: Brooks/Cole Publishers; 2005;pp. 464-509
  6. Carroll RG. Elsevier's integrated physiology. Philadelphia, PA: Mosby; 2007;
  7. Kang W, Kudsk KA. Is there evidence that the gut contributes to mucosal immunity in humans?. J Paren Enteral Nutr. 2007;31:246–258
  8. Sanders KM, Ward SM. Interstitial cells of Cajal: a new perspective on smooth muscle function. J Physiol. 2006;576:721–726
  9. Ward SM, Sanders KM. Physiology and pathophysiology of the interstitial cell of Cajal: from bench to bedside I. Functional development and plasticity of interstitial cells of Cajal networks. Am J Physiol Gastrointest Liver Physiol. 2001;281:G602–G611
  10. Griffin-Sobel J. Gastrointestinal cancers. Pittsburgh, PA: Oncology Nursing Society; 2007;
  11. Alcamo IE. Anatomy and physiology. Hauppauge. NY: Barron's Educational Series, Inc; 1996;
  12. King D. Study guide: Pancreatic islets. 2002. Available at: http://www.siumed.edu/∼dking2/erg/islets.htm (accessed May 7, 2008).
  13. Van Gerpen R. Pathophysiology. In:  Langhorne M,  Fulton J,  Otto S editor. Oncology Nursing. 5th ed. St. Louis, MO: Mosby; 2007;p. 3–16
  14. National Cancer Institutes: US National Institutes of Health. Cancer Topics. 2008. Available at: http://www.cancer.gov/cancertopics/pdq/treatment (accessed May 14, 2008).
  15. Hanahan D, Weinberg R. The hallmarks of cancer. Cell. 2000;100:57–70
  16. Verma M, Srivastava S. Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol. 2002;3:755–763
  17. Pecorino L. Molecular biology of cancer. New York, NY: Oxford University Press; 2005;
  18. Downward J. The ins and outs of signaling. Nature. 2001;411:759–762
  19. Pawson T, Jorgensen C. Signal transduction by growth factor receptors. In:  Mendelsohn J,  Howley P,  Israel M,  Gray J,  Thompson C editor. The molecular basis of cancer. 3rd ed. Philadelphia, PA: Saunders; 2008;p. 155–168
  20. Faivre S, Djelloul S, Raymond E. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Semin Oncol. 2006;33:407–420
  21. Levine A, Hu W, Feng Z. Tumor suppressor genes. In:  Mendelsohn J,  Howley P,  Israel M,  Gray J,  Thompson C editor. The molecular basis of cancer. 3rd ed. Philadelphia, PA: Saunders; 2008;p. 31–38
  22. Sebolt-Leopold JS, English JM. Mechanisms of drug inhibition of signaling molecules. Nature. 2006;44:457–462
  23. Guertin DA, Sabatini DM. Cell growth. In:  Mendelsohn J,  Howley P,  Israel M,  Gray J,  Thompson C editor. The molecular basis of cancer. 3rd ed. Philadelphia, PA: Saunders; 2008;p. 169–175
  24. Yao JC. Molecular targeted therapy for carcinoid and islet-cell carcinoma. Clin Endocrinol Metab. 2007;21:163–172
  25. Gill S, Thomas R, Goldberg R. New targeted therapies in gastrointestinal cancers. Curr Treat Options Oncol. 2003;4:393–403
  26. Posner M, Forastiere A, Minsky B. Cancer of the esophagus. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer principles and practice of oncology. 7th ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2005;p. 861–909
  27. Pisters P, Kelsen D, Powell S, Tepper J. Cancer of the stomach. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer principles and practice of oncology. 7th ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2005;p. 909–944
  28. Yeo C, Yeo T, Hruban R, et al. Cancer of the pancreas. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer principles and practice of oncology. 7th ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2005;p. 946–951
  29. Libutti S, Saltz L, Rustgi A, Tepper J. Cancer of the colon. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer principles and practice of oncology. 7th ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2005;p. 1061–1109
  30. Pang R, Poon R. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology. 2007;72(suppl 1):30–44
  31. Ciardiello F, Giampaolo T. EGFR antagonists in cancer therapy. N Engl J Med. 2008;358:1160–1174
  32. Gerber DE. Targeted therapies: a new generation of cancer treatments. Am Family Phys. 2008;77:311–319
  33. Wiedmann MW, Caca K. Molecularly targeted therapy for gastrointestinal cancer. Curr Cancer Drug Targets. 2005;5:171–193
  34. Imatinib mesylate [package insert]. East Hanover, NJ: Novartis Pharmaceutical Corporation; 2007.
  35. Kay P. Targeted therapies: a nursing perspective. Semin Oncol Nurs. 2006;22(suppl 1):1–4
  36. Braccia D. Find targeted therapy information for patients and healthcare professionals. ONS Connect. July 16, 2007;
  37. Martino Maze CD. Nursing care of patients with gastrointestinal cancer. A staff development approach. J Nurses Staff Develop. 2002;18:327–332
  38. Gemmill R, Idell CS. Biological advances for new treatment approaches. Semin Oncol Nurs. 2003;19:162–168

PII: S0749-2081(08)00073-9

doi: 10.1016/j.soncn.2008.10.002

Seminars in Oncology Nursing
Volume 25, Issue 1 , Pages 3-14 , February 2009

Article Tools

* Image Usage & Resolution